In the summer of 2024, the Hong Kong Special Administrative Region welcomed the top-level feast of the global peptide research community – 18th Chinese International Peptide Symposium (CPS 2024). CPS 2024 bought peptide researchers together around the world and promoted international communication, collaboration, and innovative applications of peptides.
Under the theme of “Integrated Development and Flourishing Peptide Potential”, the conference delved into the latest developments in cutting-edge fields such as peptides and chemistry, biology and drug discovery, and materials science. As a shining star in the field of peptide drugs and a “platinum sponsor” of this conference, Space Peptides, represented by CEO Dr.Runze HE, was invited to celebrate with colleagues around the world.
Professor Jean-Louis Reymond, Chief Scientist of Space Peptides, Founder and Major Contributor of Chemical Space New Drug Discovery Platform, and globally authoritative scientist in Peptide Drugs, attended the event and delivered a wonderful speech. Unveiling the extraordinary discovery of new peptide compounds on the Chemical Space platform; taking the breakthrough progress of antimicrobial peptide molecules AMPs with new structures and mechanisms as an example; demonstrating the company’s technological strength and drawing a grand blueprint for the future research and development of peptide drugs.
Dr.Javor Sacha, Chief Technology Officer (CTO) of Space Peptides, vividly illustrated the powerful capabilities of the Chemical Space new drug discovery platform with his unique insights into AI and big data technology. He talked about how to accelerate the process of new drug development and screening through intelligent strategies, which has sparked widespread resonance and discussion among scholars on the spot.
At this academic conference, Space Peptides showcased its profound technological accumulation in the field of new drug discovery, demonstrating the company’s leading position in peptide science research and industrialization. Space Peptides has an unwavering pursuit of scientific exploration. We deeply understand that in the vast expanse of peptide science, only by constantly moving forward can we explore the unknown and create the future. We will continue to adhere to the concept of “Innovation-Led, Technology-Driven”, continuously invest in technological innovations, rely on strong technical strength and advanced technology, and work together with colleagues around the world to promote the prosperous development of peptide science.
